Filing Details

Accession Number:
0001209191-19-060531
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-13 20:04:50
Reporting Period:
2019-12-13
Accepted Time:
2019-12-13 20:04:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1510487 Principia Biopharma Inc. PRNB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1506218 C. Roy Hardiman C/O Principia Biopharma Inc.
220 E. Grand Avenue
South San Francisco CA 94080
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-13 871 $4.72 121,014 No 4 M Direct
Common Stock Acquisiton 2019-12-13 4,129 $5.00 125,143 No 4 M Direct
Common Stock Disposition 2019-12-13 3,381 $49.20 121,762 No 4 S Direct
Common Stock Disposition 2019-12-13 1,619 $49.83 120,143 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2019-12-13 871 $0.00 871 $4.72
Common Stock Employee Stock Option (right to buy) Disposition 2019-12-13 4,129 $0.00 4,129 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,758 2025-02-25 No 4 M Direct
0 2025-07-20 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,376 Indirect See footnote
Footnotes
  1. Includes 2,500 shares and 441 shares acquired under the Employment Stock Purchase Plan on May 15, 2019 and November 15, 2019 respectively.
  2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  3. Represents the weighted average sales price per share. The shares sold at prices ranging from $48.49 to $49.48 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  4. Represents the weighted average sales price per share. The shares sold at prices ranging from $49.57 to $50.04 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  5. Shares indirectly held by Roy Hardiman, as Custodian for Riley James Hardiman, Under California Uniform Transfers to Minors Act, of which the Reporting Person is a custodian and may be deemed to share voting and dispositive power over these shares.
  6. The stock option vested and became exercisable as to 25% of the shares subject to the option on January 5, 2016, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
  7. The stock option vested and became exercisable as to 25% of the shares subject to the option on July 21, 2016, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.